Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

692 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
Hurria A, Goldfarb S, Rosen C, Holland J, Zuckerman E, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Robson M, Currie VE, Theodoulou M, Norton L, Hudis C. Hurria A, et al. Among authors: goldfarb s. Breast Cancer Res Treat. 2006 Aug;98(3):343-8. doi: 10.1007/s10549-006-9171-6. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541322
Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy.
Damast S, Alektiar KM, Goldfarb S, Eaton A, Patil S, Mosenkis J, Bennett A, Atkinson T, Jewell E, Leitao M, Barakat R, Carter J, Basch E. Damast S, et al. Among authors: goldfarb s. Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e187-93. doi: 10.1016/j.ijrobp.2012.03.030. Epub 2012 May 8. Int J Radiat Oncol Biol Phys. 2012. PMID: 22572074 Free PMC article.
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients.
Oseledchyk A, Gemignani ML, Zhou QC, Iasonos A, Elahjji R, Adamou Z, Feit N, Goldfarb SB, Long Roche K, Sonoda Y, Goldfrank DJ, Chi DS, Saban SS, Broach V, Abu-Rustum NR, Carter J, Leitao M, Zivanovic O. Oseledchyk A, et al. Among authors: goldfarb sb. Int J Gynecol Cancer. 2021 Feb;31(2):222-231. doi: 10.1136/ijgc-2020-001966. Epub 2020 Dec 3. Int J Gynecol Cancer. 2021. PMID: 33273020 Free PMC article.
Bevacizumab for advanced breast cancer.
Goldfarb SB, Traina TA, Dickler MN. Goldfarb SB, et al. Womens Health (Lond). 2010 Jan;6(1):17-25. doi: 10.2217/whe.09.71. Womens Health (Lond). 2010. PMID: 20001867 Free article. Review.
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
Jhaveri K, Chandarlapaty S, Lake D, Gilewski T, Robson M, Goldfarb S, Drullinsky P, Sugarman S, Wasserheit-Leiblich C, Fasano J, Moynahan ME, D'Andrea G, Lim K, Reddington L, Haque S, Patil S, Bauman L, Vukovic V, El-Hariry I, Hudis C, Modi S. Jhaveri K, et al. Among authors: goldfarb s. Clin Breast Cancer. 2014 Jun;14(3):154-60. doi: 10.1016/j.clbc.2013.12.012. Epub 2013 Dec 28. Clin Breast Cancer. 2014. PMID: 24512858 Clinical Trial.
692 results